ContentsSynopsisCodesDifferential Diagnosis & PitfallsBest TestsReferences
Parathyroid carcinoma
Other Resources UpToDate PubMed

Parathyroid carcinoma

Contributors: Benjamin L. Mazer MD, MBA, Marilyn Augustine MD
Other Resources UpToDate PubMed

Synopsis

Clonal malignant cells originating in the parenchyma of the inferior parathyroid glands. Uncommonly in the mediastinum. Onset of parathyroid carcinoma may be related to excessive parathyroid hormone production, leading to primary hyperparathyroidism. Characterized by greatly elevated parathyroid hormone (PTH) and moderate to severe hypercalcemia. Often presenting with a neck mass. Other signs and symptoms include bone pain, dysphagia, dysphonia, muscle weakness, nausea, and vomiting.

Pathologic confirmation of capsular, perineural, or blood vessel invasion of parathyroid adjacent structures or distant metastases can distinguish malignancy from benign adenoma. Untreated, parathyroid gland carcinoma has a poor prognosis. The likely cause of death is due to complications caused by hypercalcemia.

Management includes surgical "en bloc" resection of ipsilateral lobe and involved tissue. More severe malignancy calls for comprehensive resection. Radiation therapy has mixed reviews. Chemotherapy has not garnered positive results; however, treatment of hypercalcemia by pharmacotherapies can provide temporary relief of symptoms. Calcimimetics (to decrease PTH production) may reduce complications and extend survival time.

Codes

ICD10CM:
C75.0 – Malignant neoplasm of parathyroid gland

SNOMEDCT:
255037004 – Parathyroid carcinoma

Differential Diagnosis & Pitfalls

Parathyroid masses:
Hyperparathyroidism:

Best Tests

Subscription Required

References

Subscription Required

Last Updated:08/12/2016
Copyright © 2021 VisualDx®. All rights reserved.
Parathyroid carcinoma
Print  
Parathyroid carcinoma : Nausea/vomiting, Bone pain, Muscle weakness, Neck mass, Dysphagia, Dysphonia, Ca elevated
Copyright © 2021 VisualDx®. All rights reserved.